Bill Ackman's presentation failed to impress investors, but it probably should have, as Ackman raised several important points.
The post-market springboard of Intuitive Surgical’s stock, as impressive as it may be, appears more tied to this market’s over-reaction to even the slightest bit of good news, rather than the kind of news that would definitively suggest a sustainable recovery is in the works.
If the 25% rise in Herbalife's stock proves nothing else, it's that the market hates 'anticappointment,' as one friend puts it, referring to Ackman's highly promoted multi-hour presentation.
Allergan is in a tight spot: It had better hope, if it's successful fighting off Valeant, that its stock price doesn't tumble -- and in a year has rebounded!
Michael Kors challenged Herb Greenberg's observation regarding the company's upcoming earnings report and analysts' recent negative action.
The surprising thing about Western Union is that its stock is as high as it is. Its legendary moat of “trust, reliability, speed, and convenience,” which historically has allowed for premium pricing, appears to be drying up as competition has flourished.
Analyst reports on Michael Kors seem to hint that the company has been quietly telegraphing a disappointing earnings report.
Green-flagged Tibco's shares rose Thursday, bouncing off 12-month lows, after investor Praesidium Investment Management made its case.
Former Watch List company RealPage lowered the boom after the market close Thursday, saying second-quarter results will be sharply worse than expected
In recent days the same story has run in two Chinese business publications -- China Business News and the China Business Journal – suggesting Usana may be in violation of China’s direct-selling rules.